IRRAS's Nomination Committee Proposes Ms. Catherine Gilmore-Lawless as New Board Member

STOCKHOLM, May 3, 2019 /PRNewswire/ -- IRRAS AB (Nasdaq First North Premier: IRRAS), a commercial-stage medical-technology company, today announced that the company's nomination committee recommends Ms. Catherine Gilmore-Lawless to be a new IRRAS board member. On April 15, 2019, in the...

from PR Newswire: http://bit.ly/2Y2Ya3S